Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways

// Reetobrata Basu 1, 2 , Shiyong Wu 1, 2 , John J. Kopchick 1, 2, 3 1 Edison Biotechnology Institute, Ohio University, Athens, Ohio, USA 2 Molecular and Cell Biology Program, Ohio University, Athens, Ohio, USA 3 Ohio University Heritage College of Osteopathic Medicine, Athens, Ohio, USA Correspondence to: John J. Kopchick, email: kopchick@ohio.edu Keywords: growth hormone (GH), growth hormone receptor (GHR), melanoma, cancer, IGF-1 Received:...